FASLG and systemic lupus erythematosus: Dimerisation of β2GPI by aPL substantially increases the phospholipid binding of β2GPI and the lupus anticoagulant activity of aPL [40,41], with β2GPI dimers mimicking the in vitro activity of aβ2GPI-β2GPI complexes [42].